Vincerx Pharma Company Insiders

VINC Stock  USD 0.26  0.01  4.00%   
Vincerx Pharma's insiders are aggressively buying. The analysis of the overall insider sentiment regarding Vincerx Pharma suggests that all insiders are extremely bullish. Vincerx Pharma employs about 42 people. The company is managed by 15 executives with a total tenure of roughly 98 years, averaging almost 6.0 years of service per executive, having 2.8 employees per reported executive.

Vincerx Pharma's Insider Buying Vs Selling

100

 
Selling
 
Buying

Latest Trades

2023-08-11Alexander A SeelenbergerAcquired 10500 @ 0.95View
2023-08-09Ahmed Md HamdyAcquired 16900 @ 0.95View
2022-12-14Raquel E IzumiAcquired 28738 @ 0.88View
2022-08-24Christopher P LoweAcquired 18400 @ 1.65View
2022-06-27Raquel E IzumiAcquired 40000 @ 1.41View
2022-06-23Ahmed Md HamdyAcquired 24200 @ 1.41View
2022-06-09Laura I BushnellAcquired 15000 @ 1.91View
2021-12-22Laura I BushnellAcquired 2402 @ 10.48View
Monitoring Vincerx Pharma's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vincerx Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade Vincerx Stock refer to our How to Trade Vincerx Stock guide.

Vincerx Pharma Management Team Effectiveness

The company has return on total asset (ROA) of (0.6599) % which means that it has lost $0.6599 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.4245) %, meaning that it created substantial loss on money invested by shareholders. Vincerx Pharma's management efficiency ratios could be used to measure how well Vincerx Pharma manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -2.09. The current year's Return On Capital Employed is expected to grow to -3.21. At present, Vincerx Pharma's Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Debt To Assets is expected to grow to 0.07, whereas Total Assets are forecasted to decline to about 17.3 M.
As of November 28, 2024, Common Stock Shares Outstanding is expected to decline to about 17.3 M. The current year's Net Loss is expected to grow to about (55.9 M)

Vincerx Pharma Workforce Comparison

Vincerx Pharma is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 1,411. Vincerx Pharma holds roughly 42.0 in number of employees claiming about 2.98% of equities under Health Care industry.

Vincerx Pharma Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Vincerx Pharma insiders, such as employees or executives, is commonly permitted as long as it does not rely on Vincerx Pharma's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Vincerx Pharma insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Vincerx Pharma Notable Stakeholders

A Vincerx Pharma stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Vincerx Pharma often face trade-offs trying to please all of them. Vincerx Pharma's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Vincerx Pharma's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Tom JDGeneral FounderProfile
Ahmed MDChairman CoFounderProfile
Raquel IzumiPresident, CoFounderProfile
Raj MBAVP ManufacturingProfile
Melissa SPHRDirector CultureProfile
Karen QuarfordVice ComplianceProfile
Karen MBAVice ComplianceProfile
John MDFounder BoardProfile
Beatrix StelteLudwigExecutive OfficerProfile
HansGeorg LerchenChief OfficerProfile
Steven RPhChief OfficerProfile
MBA MBAChief OfficerProfile
David MBAHead DevelProfile
Alexander MBAChief OfficerProfile
Gabriela JairalaSr CommunicationsProfile

About Vincerx Pharma Management Performance

The success or failure of an entity such as Vincerx Pharma often depends on how effective the management is. Vincerx Pharma management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Vincerx management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Vincerx management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(2.20)(2.09)
Return On Capital Employed(3.38)(3.21)
Return On Assets(2.20)(2.09)
Return On Equity(3.58)(3.40)
Please note, the presentation of Vincerx Pharma's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Vincerx Pharma's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Vincerx Pharma's management manipulating its earnings.

Vincerx Pharma Workforce Analysis

Traditionally, organizations such as Vincerx Pharma use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Vincerx Pharma within its industry.

Vincerx Pharma Manpower Efficiency

Return on Vincerx Pharma Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee956.1K
Net Loss Per Executive2.7M
Working Capital Per Employee217.3K
Working Capital Per Executive608.5K

Complementary Tools for Vincerx Stock analysis

When running Vincerx Pharma's price analysis, check to measure Vincerx Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vincerx Pharma is operating at the current time. Most of Vincerx Pharma's value examination focuses on studying past and present price action to predict the probability of Vincerx Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vincerx Pharma's price. Additionally, you may evaluate how the addition of Vincerx Pharma to your portfolios can decrease your overall portfolio volatility.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators